vimarsana.com

Seed Fund supports move towards Clinical Development

Card image cap

SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis has announced €1. Click to read more...

Related Keywords

Morgane Rousselot , , Professor Kinet , Disorders , Ouxlife , Liver , Eabelife , Company , Drug , Candidates , Fell , Funding , Strategic ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.